Editors:
- Provides overview of the global pharmaceutical pricing policies
- Covers pharmaceutical pricing strategies in 19 countries
- Provides specific chapters on value-based pricing, innovation, prices and the pharmaceutical industry and the link between pharmaceutical policy and pricing
- Includes supplementary material: sn.pub/extras
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (22 chapters)
-
Front Matter
About this book
Reviews
“This book is a collection of national case studies about pharmaceutical pricing policy. … this book offers a wealth of examples to consider, especially for low- and middle-income countries that are in the process of changing or establishing health insurance programs. Having a consolidated reference source, such as this book, for academics interested in the field of policy analysis will obviously be very useful.” (Suzanne Rose Hill, PharmacoEconomics, Vol. 34 (3), March, 2016)
Editors and Affiliations
-
Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand
Zaheer-Ud-Din Babar
Bibliographic Information
Book Title: Pharmaceutical Prices in the 21st Century
Editors: Zaheer-Ud-Din Babar
DOI: https://doi.org/10.1007/978-3-319-12169-7
Publisher: Adis Cham
eBook Packages: Business and Economics, Economics and Finance (R0)
Copyright Information: Springer International Publishing Switzerland 2015
Hardcover ISBN: 978-3-319-12168-0Published: 18 December 2014
Softcover ISBN: 978-3-319-35009-7Published: 23 August 2016
eBook ISBN: 978-3-319-12169-7Published: 05 December 2014
Edition Number: 1
Number of Pages: X, 411
Number of Illustrations: 3 b/w illustrations, 34 illustrations in colour
Topics: Health Economics